Drug Name:
COLAZAL Rx
Generic Name and Formulations:
Balsalazide disodium (prodrug of mesalamine) 750mg; caps.
Company:
Valeant Pharmaceuticals, Inc
Therapeutic Use:
Indications for COLAZAL:
Mildly to moderately active ulcerative colitis.
Adult:
May swallow whole or sprinkle capsule contents into applesauce. 2.25g 3 times daily for 8 weeks; max 12 weeks.
Children:
May swallow whole or sprinkle capsule contents into apple sauce. <5yrs: not recommended. ≥5yrs: 2.25g 3 times daily or 750mg 3 times daily; max 8 weeks.
Warnings/Precautions:
Pyloric stenosis. Renal dysfunction. History of renal disease. Pregnancy (Cat.B). Nursing mothers.
Pharmacological Class:
Salicylate.
Adverse Reactions:
Headache, GI upset/pain, arthralgia, respiratory infection, insomnia, fatigue, anorexia, exacerbation of symptoms, pyrexia.
How Supplied:
Caps—280, 500
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- The Symbiosis of Headache and Sleep
- Neurosurgery in Parkinson Disease: A Brief History and Look Forward
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Blood Pressure-Dementia Link May Be Affected by Population Characteristics
- The Consequences of Compensation in Autism
- Micronutrient Levels May Be Altered in ADHD
- MIND Diet Linked to Slower Cognitive Decline Among Stroke Survivors
- Ozanimod Superior to Interferon β-1a for Treatment of Relapsing Multiple Sclerosis
- Comorbidity More Likely With Chronic Migraine vs Episodic Migraine
- Eptinezumab for Frequent Episodic Migraine: Results of Phase 3 PROMISE-1 Study